Cardiovascular Safety of Denosumab Across Multiple Indications
| Errataetall: |
CommentOn: J Bone Miner Res. 2021 Jan;36(1):24-40. - PMID 32780899 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:36 |
|---|---|
| Enthalten in: |
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research - 36(2021), 3 vom: 23. März, Seite 617-618 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Shao, Long [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
4EQZ6YO2HI |
|---|
| Anmerkungen: |
Date Completed 09.08.2021 Date Revised 09.08.2021 published: Print-Electronic CommentOn: J Bone Miner Res. 2021 Jan;36(1):24-40. - PMID 32780899 Citation Status MEDLINE |
|---|
| doi: |
10.1002/jbmr.4189 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM316643211 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM316643211 | ||
| 003 | DE-627 | ||
| 005 | 20231225161530.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1002/jbmr.4189 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1055.xml |
| 035 | |a (DE-627)NLM316643211 | ||
| 035 | |a (NLM)33095450 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Shao, Long |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Cardiovascular Safety of Denosumab Across Multiple Indications |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 09.08.2021 | ||
| 500 | |a Date Revised 09.08.2021 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: J Bone Miner Res. 2021 Jan;36(1):24-40. - PMID 32780899 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Bone Density Conservation Agents |2 NLM | |
| 650 | 7 | |a Denosumab |2 NLM | |
| 650 | 7 | |a 4EQZ6YO2HI |2 NLM | |
| 700 | 1 | |a Wu, Xiang-Dong |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Wei |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research |d 1991 |g 36(2021), 3 vom: 23. März, Seite 617-618 |w (DE-627)NLM012611115 |x 1523-4681 |7 nnns |
| 773 | 1 | 8 | |g volume:36 |g year:2021 |g number:3 |g day:23 |g month:03 |g pages:617-618 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1002/jbmr.4189 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 36 |j 2021 |e 3 |b 23 |c 03 |h 617-618 | ||